How to Evaluate GenAI Tools: Considerations for Marketers
Considerations for marketers—regarding data, copyright, cost and use cases—when evaluating new GenAI tools.
Considerations for marketers—regarding data, copyright, cost and use cases—when evaluating new GenAI tools.
According to Gartner’s latest Hype Cycle, which focused on evaluating CDPs for the first time, the technology is less appealing to the marketing industry than it was a few years ago.
Five things B2B marketers can do right now to succeed in a cookieless world.
A five-step approach to strategically master programmatic advertising for B2B audiences.
RFP season is now upon us. With tight budgets and tough goals, retail marketers are hoping to get more juice from the squeeze. Here's how brands can ask the right questions to find those partners who can really make a big difference.
Part two of our chat with the marketing chief, which covers the healthcare business post-pandemic, new channels to reach audiences and how regional targeting will factor into Blue Cross Blue Shield's marketing strategy.
Our latest Marketers on Fire profile features Kelly Calabria, Chief Marketing and CSR Officer at Blue Cross Blue Shield of North Carolina, who examines three challenges her brand is facing in 2024.
How will B2B marketing adapt to the GenAI craze in 2024? Here are three predictions.
A look at B2B integrated marketing and communications challenges in the coming year amid uncertain economic times.
The honorees for the Chief Marketer 2023 Top Women in Marketing Awards have been revealed.
Click here to view the 2023 winners!